Table 3.
Parameter | All (n = 639) | No cRBBB ≤ 30 days after HTX (n = 500) | cRBBB ≤ 30 days after HTX (n = 139) | Difference | 95% CI | P‐value |
---|---|---|---|---|---|---|
Graft failure, n (%) | 55 (8.6%) | 10 (2.0%) | 45 (32.4%) | 30.4% | 22.5%–38.3% | <0.01* |
Acute rejection, n (%) | 4 (0.6%) | 3 (0.6%) | 1 (0.7%) | 0.1% | −1.5%–1.7% | 0.87 |
Infection/sepsis, n (%) | 75 (11.7%) | 45 (9.0%) | 30 (21.6%) | 12.6% | 5.3%–19.9% | <0.01* |
Malignancy, n (%) | 3 (0.5%) | 2 (0.4%) | 1 (0.7%) | 0.3% | −1.2%–1.8% | 0.63 |
Thromboembolic event/bleeding, n (%) | 10 (1.6%) | 8 (1.6%) | 2 (1.4%) | 0.2% | −2.1 – 2.5% | 0.89 |
All causes, n (%) | 147 (23.0%) | 68 (13.6%) | 79 (56.8%) | 43.2% | 34.4%–52.0% | <0.01* |
CI, confidence interval; cRBBB, complete right bundle branch block; HTX, heart transplantation; n, number.
Statistically significant at P < 0.05.